0000000001325830

AUTHOR

Marica Parrinello

showing 9 related works from this author

FOLLOW UP A LUNGO TERMINE DI PAZIENTI CON POSITIVITA’ DELLA NMP22 E NEGATIVITA’ CISTOSCOPICA E CITOLOGICA

2005

researchProduct

TERAPIA DI II LINEA NEL CARCINOMA PROSTATICO ORMONOREFRATTARIO (HRPC) CON ESTRAMUSTINA FOSFATO ED ETOPOSIDE. STUDIO DI FASE II DEL GSTU

2005

researchProduct

INCIDENTAL ULTRASOUND FINDINGS IN A GREAT POPULATION OF SUBFERTILE PATIENTS: OUR EXPERIENCE AND DESCRIPTION OF A PARADOXICAL ONCOLOGICAL DISEASE

2006

education.field_of_studymedicine.medical_specialtybusiness.industryUrologyGeneral surgeryPopulationUltrasoundmedicineDiseaseeducationbusinessSurgeryEuropean Urology Supplements
researchProduct

Results of a Phase I-II Pilot Study with Intravescical Gemcitabine in Superficial Bladder Cancer (Ta-T1)

2005

To study the ablative activity of intravescical gemcitabine against superficial transitional cell carcinoma of the bladder at different doses and concentrations. Methods Twenty-seven patients were treated with intravescical gemcitabine after transurethral resection, during which one to three papillary marker lesions were left unresected. Starting 14 days after transurethral resection, six gemcitabine instillations were given at weekly intervals. Gemcitabine, diluted in 50 mL of saline solution and maintained for 2 hr, was given at a dose of 500, 1000 and 2000 mg in groups of nine patients each. A complete response (CR) was defined as negative cutologycystoscopy and biopsy findings. Results…

medicine.medical_specialtybusiness.industry030232 urology & nephrologyUrologyGeneral Medicinemedicine.diseaseGemcitabine03 medical and health sciences0302 clinical medicinePhase i iiTransitional cell carcinomaTolerability030220 oncology & carcinogenesisAblative casemedicineSuperficial bladder cancerbusinessmedicine.drugUrologia Journal
researchProduct

Chemioterapia domiciliare nel carcinoma prostatico ormonorefrattario (HRPC). Studio di fase II del gruppo studio tumori urologici (GSTU).

2005

researchProduct

POSITIVITA’ DELL’NMP22 E NEGATIVITA’ CISTOSCOPICA E CITOLOGICA. QUALE SIGNIFICATO ATTRIBUIRE?

2005

researchProduct

Risultati di uno studio pilota di fase I-II con gemcitabina endovescicale nel tumore vescicale superficiale (TA-T1)

2005

researchProduct

Trattamento sclerotizzante retrogrado percutaneo del varicocele e risultati sui parametri seminali e sulla fertilità.

2006

Comunicazione orale per XIII Congresso Nazionale della Società Italiana di Andrologia. Milano, 26-29 settembre 2006

sclerotizzazione varicocele fertilitàSettore MED/36 - Diagnostica Per Immagini E RadioterapiaSettore MED/24 - Urologia
researchProduct

Paradoxical arterial priapism: post-traumatic monolateral low penile perfusion and curvature associated to contro-lateral arterious-cavernous acerati…

2006

Poster for IX Congress of the European Society for Sexual Medicine. Vienna, Dicember 3th – 6th 2006

paradoxal arterial priapismSettore MED/36 - Diagnostica Per Immagini E RadioterapiaSettore MED/24 - Urologia
researchProduct